What is the recommended amoxicillin dosing regimen for cellulitis in adults and children, including adjustments for renal impairment and severe infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amoxicillin Dosing for Cellulitis

Amoxicillin alone is NOT recommended as first-line therapy for typical cellulitis because it lacks adequate coverage for the most common pathogens (β-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus). 1, 2

Appropriate Use of Amoxicillin-Based Therapy

Amoxicillin should only be used for cellulitis when combined with a beta-lactamase inhibitor (amoxicillin-clavulanate) in specific clinical scenarios:

Standard Dosing for Non-Purulent Cellulitis

While the IDSA guidelines do not list amoxicillin-clavulanate as a primary agent for typical cellulitis 1, it appears in their recommendations for:

Animal/Human Bite-Related Cellulitis:

  • Adults: Amoxicillin-clavulanate 875/125 mg twice daily orally 1
  • Children: 25 mg/kg/day (based on amoxicillin component) divided into 2 doses orally 1

Impetigo (which can progress to cellulitis):

  • Adults: Amoxicillin-clavulanate 875/125 mg twice daily orally 1
  • Children: 25 mg/kg/day (amoxicillin component) in 2 divided doses orally 1

Why Plain Amoxicillin Fails for Cellulitis

The majority of non-purulent cellulitis cases are caused by β-hemolytic streptococci or methicillin-sensitive S. aureus 2. While amoxicillin covers streptococci adequately, many S. aureus strains produce beta-lactamase, rendering plain amoxicillin ineffective. The IDSA guidelines specifically recommend agents like cephalexin (500 mg four times daily in adults; 25-50 mg/kg/day in 4 divided doses in children) or dicloxacillin as preferred oral agents for methicillin-susceptible strains 1.

Renal Dose Adjustments

For patients with renal impairment requiring amoxicillin-based therapy:

The pharmacokinetics of amoxicillin are significantly altered in renal failure, with decreased elimination half-life and total body clearance 3. Dose adjustment is essential to prevent toxicity while maintaining efficacy 4, 5.

Adjustment Algorithm:

  • CrCl >30 mL/min: No adjustment needed
  • CrCl 10-30 mL/min: Reduce frequency to once or twice daily (extend dosing interval)
  • CrCl <10 mL/min: Maximum 500 mg every 24 hours
  • Hemodialysis: Administer dose after dialysis session (hemodialysis half-life is approximately 2.3 hours) 3

The linear relationship between amoxicillin elimination and creatinine clearance allows for predictable dose adjustments 3.

Critical Clinical Pitfalls

Do not use amoxicillin monotherapy for typical cellulitis. The appropriate first-line oral agents are:

  • Cephalexin 500 mg four times daily (adults) 1
  • Dicloxacillin 500 mg four times daily (adults) 1
  • For children: Cephalexin 25-50 mg/kg/day in 4 divided doses 1

Reserve amoxicillin-clavulanate for:

  • Bite-related infections (animal or human)
  • Polymicrobial infections
  • Situations where broader anaerobic coverage is needed

MRSA coverage is generally NOT needed for non-purulent cellulitis, even with rising community-acquired MRSA rates 2. Add MRSA-active agents (trimethoprim-sulfamethoxazole, doxycycline, or clindamycin) only if purulent drainage is present, systemic toxicity develops, or initial therapy fails 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.